Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel disease
{{output}}
Background: Patients who receive infliximab (IFX) combined with a thiopurine, for inflammatory bowel disease, have a better clinical response and less frequent immunization towards IFX than those treated with IFX alone. The benef... ...
